Read our news

On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.

This October, HTL Biotechnology turned pink to support breast cancer prevention.

HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.

The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.

We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.

A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.

As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.

HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.

HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.

We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.

On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo)  in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.

Earlier this year, during the IMCAS World Congress, we interviewed three experts in the field of aesthetic medicine and are thrilled to share these interviews !